Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments

Biochemical and Biophysical Research Communications

Volumn 324, Issue 1, 2004, Pages 92-97

  Lenhard, James M ^a   Croom, Dallas K ^a   Minnick, Dana T ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Diabetes; Dipeptidyl peptidase IV; Glucagon like peptide 1; Glyburide; Metformin; Pioglitazone

Indexed keywords

D 5035; DIPEPTIDYL PEPTIDASE IV; G 0639; GLIBENCLAMIDE; METFORMIN; PIOGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; GLYCOSYLATION; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGRESSION ANALYSIS;

AGING; ANIMALS; ANTIGENS, CD26; BLOOD GLUCOSE; CELL MEMBRANE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; GLYBURIDE; HEMOGLOBINS; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; LIVER; MALE; METFORMIN; PEPTIDE FRAGMENTS; PPAR GAMMA; PROTEIN PRECURSORS; RATS; RATS, ZUCKER; THIAZOLIDINEDIONES;

EID: 4744356246     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.09.021     Document Type: Article

References (25)

1. J.M. Lehmann, L.B. Moore, T.A. Smith-Oliver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) J. Biol. Chem. 270 1995 12953 12956
2. J.M. Lenhard PPAR gamma/RXR as a molecular target for diabetes Receptors Channels 8 2001 249 258
3. L. Luzi, and G. Pozza Glibenclamide: an old drug with a novel mechanism of action? Acta Diabetol. 34 1997 239 244
4. A.E. Boyd The role of ion channels in insulin secretion J. Cell. Biochem. 48 1992 235 241
5. R. Defronzo Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects J. Clin. Endocrinol. Metab. 73 1991 1294 1301
6. C.L. Li, C.Y. Pan, J.M. Lu, Y. Zhu, J.H. Wang, X.X. Deng, F.C. Xia, H.Z. Wang, and H.Y. Wang Effect of metformin on patients with impaired glucose tolerance Diabet. Med. 16 1999 477 481
7. I. De Meester, C. Durinx, G. Bal, P. Proost, S. Struyf, F. Goossens, K. Augustyns, and S. Scharpe Natural substrates of dipeptidyl peptidase IV Adv. Exp. Med. Biol. 477 2000 67 87
8. D.J. Drucker Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes Expert Opin. Invest. Drugs 12 2003 87 100
9. D. Marguet, L. Baggio, T. Kobayashi, A.M. Bernard, M. Pierres, P.F. Nielsen, U. Ribel, T. Watanabe, D.J. Drucker, and N. Wagtmann Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26 Proc. Natl. Acad. Sci. USA 97 2000 6874 6879
10. R.A. Pederson, H.A. White, D. Schlenzig, R.P. Pauly, C.H. McIntosh, and H.U. Demuth Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide Diabetes 47 1998 1253 1258
11. E. Mannucci, A. Ognibene, F. Cremasco, G. Bardini, A. Mencucci, E. Pierazzuoli, S. Ciani, G. Messeri, and C.M. Rotella Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects Diabetes Care 24 2001 489 494
12. N. Yasuda, T. Inoue, T. Nagakura, K. Yamazaki, K. Kira, T. Saeki, and I. Tanaka Enhanced secretion of glucagon-like peptide 1 by biguanide compounds Biochem. Biophys. Res. Commun. 298 2002 779 784
13. S.A. Hinke, K. Kuhn-Wache, T. Hoffmann, R.A. Pederson, C.H. McIntosh, and H.U. Demuth Metformin effects on dipeptidylpeptidase IV degradation of glucagon-like peptide-1 Biochem. Biophys. Res. Commun. 291 2002 1302 1308
14. J.E. Cobb, S.G. Blanchard, and E.G. Boswell N-(2-Benzoylphenyl)-l- tyrosine PPAR agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent J. Med. Chem. 41 1998 5055 5069
15. C. Durinx, A.M. Lambeir, E. Bosmans, J.B. Falmagne, R. Berghmans, A. Haemers, S. Scharpe, and I. De Meester Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides Eur. J. Biochem. 267 2000 5608 5613
16. E.B. Villhauer, J.A. Brinkman, G.B. Naderi, B.F. Burkey, B.E. Dunning, K. Prasad, B.L. Mangold, M.E. Russell, and T.E. Hughes 1-[[(3-Hydroxy-1-adamantyl) amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties J. Med. Chem. 46 2003 2774 2789
17. W.N. Dinjens, J. Ten Kate, E.P. van der Linden, J.T. Wijnen, P.M. Khan, and F.T. Bosman Distribution of adenosine deaminase complexing protein (ADCP) in human tissues J. Histochem. Cytochem. 37 1989 1869 1875
18. T. Aoyagi, T. Wada, F. Kojima, M. Nagai, Y. Akanuma, H. Akanuma, and H. Umezawa Relation of blood glucose levels to the changes in plasma levels of various hydrolytic enzymes in diabetic patients Biochem. Int. 10 1985 821 827
19. J.M. Lenhard, R. Malhotra, The role of dipeptidyl peptidase IV/CD26 inhibitors in disease, Prog. Diabetes Res. (2004) in press
20. M.B. Toft-Nielsen, S. Madsbad, and J.J. Holst Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes J. Clin. Endocrinol. Metab. 86 2001 3853 3860
21. J.E. Scherberich, J. Wiemer, and W. Schoeppe Biochemical and immunological properties of urinary angiotensinase A and dipeptidylaminopeptidase IV. Their use as markers in patients with renal cell injury Eur. J. Clin. Chem. Clin. Biochem. 30 1992 663 668
22. J.M. Lenhard, and D.K. Croom The peroxisome proliferator activated receptor gamma ligand GW7845 decreases dipeptidyl peptidase IV activity in the plasma of diabetic rats Diabetes 51 Suppl. 2 2002 341
23. Y. Agrawal, and T. Vanha-Perttula Dipeptidyl peptidases in bovine reproductive organs and secretions Int. J. Androl. 9 1986 435 452
24. S. Hatachi, Y. Iwai, S. Kawano, S. Morinobu, M. Kobayashi, M. Koshiba, R. Saura, M. Kurosaka, T. Honjo, and S. Kumagai CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid J. Rheumatol. 30 2003 1410 1419
25. M.D. Poulsen, G.H. Hansen, E. Dabelsteen, P.E. Hoyer, O. Noren, and H. Sjostrom Dipeptidyl peptidase IV is sorted to the secretory granules in pancreatic islet A-cells J. Histochem. Cytochem. 41 1993 81 88